Bayesian Capital Management, LP Takeda Pharmaceutical CO LTD Transaction History

Bayesian Capital Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$13.54 - $15.35 $205,767 - $233,273	-15,197 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$13.17 - $16.4 $200,144 - $249,230	15,197 New	15,197 $207,000
Q3 2021 Nov 15, 2021	SELL	$16.3 - $17.26 $231,818 - $245,471	-14,222 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$16.55 - $18.64 $306,423 - $345,119	-18,515 Reduced 56.56%	14,222 $239,000
Q1 2021 May 14, 2021	BUY	$16.71 - $19.9 $238,953 - $284,570	14,300 Added 77.56%	32,737 $598,000
Q4 2020 Feb 12, 2021	BUY	$15.39 - $18.97 $79,135 - $97,543	5,142 Added 38.68%	18,437 $336,000
Q3 2020 Nov 12, 2020	BUY	$17.1 - $19.19 $227,344 - $255,131	13,295 New	13,295 $237,000
Q2 2020 Aug 14, 2020	SELL	$14.59 - $19.5 $295,914 - $395,499	-20,282 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$13.02 - $20.31 $264,071 - $411,927	20,282 New	20,282 $308,000

338

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.5B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.